Access to Medicines

SDG 3 seeks to ensure healthy lives and promote well-being for all and SDG 17 seeks strengthening global partnerships between public, private and government agencies as an essential ingredient in ensuring a brighter and healthier future.

So how are public - private partnerships meeting these goals both for innovation and access? What are the key features of "innovative business models" and how do these models and the cooperation with the private sector and other stakeholders meet expectations? What can we do to ensure both innovation and access especially for essential and neglected treatments? How do communities see these partnerships?

A panel of leaders of public health partnerships from differing treatment fields and with different business models have been brought together to discuss these challenges and seek to explain how their partnerships are making real impact in achieving SDGs especially in developing countries.